MSH|^~\&|LAB|ARH|||201911151411||ORU^R01|4106541|D|2.3|||AL|NE
PID|1||AB00008248|AB8147|LABTEST^HFE^||20010101|F||||||||||AB000498/19|9875034351
OBR|1|35217^LAB|00027054^1511:C00005R^LAB^151119:C5^35217|220.5080^HFE CD^Hemochromatosis-Conf Diagnosis^^^XXX-1182||201911151403|201911151403|||||||201911151403||||||||||LAB|I||||
OBR|2|35217^LAB|00027054^1511:C00005R^LAB^151119:C5^35217|520.4200^IRON^Iron Studies Profile^^^50190-8||201911151403|201911151403|||||||201911151403||||||||||LAB|F||||
OBX|1|ST|520.4300^FE^Iron^^14798-3^14798-3|1|30^^Y|umol/L|9-30|N||A^S|F|||201911151411
OBX|2|ST|520.4500^TIBC^Total Iron Binding Capacity^^14800-7^14800-7|1|40^^Y|umol/L|45-70|L||A^S|F|||201911151411
OBX|3|ST|520.4600^TRFSAT^Transferrin Saturation^^6796-7^14801-5|1|0.75^^Y||0.15-0.55|H||A^S|F|||201911151411
NTE|1||Markedly elevated transferrin saturation.  Follow up and
NTE|2||management as per BCMA/MSP Iron Overload protocol.

MSH|^~\&|LAB|ARH|||201911151412||ORU^R01|4106542|D|2.3|||AL|NE
PID|1||AB00008248|AB8147|LABTEST^HFE^||20010101|F||||||||||AB000498/19|9875034351
OBR|1|35217^LAB|00027054^1511:C00005R^LAB^151119:C5^35217|220.5080^HFE CD^Hemochromatosis-Conf Diagnosis^^^XXX-1182||201911151403|201911151403|||||||201911151403||||||||||LAB|F||||
OBX|1|ST|520.4700^FER^Ferritin^^2276-4^2276-4|1|350^^Y|ug/L|15-200|H||A^S|F|||201911151412
OBR|2|35217^LAB|00027054^1511:C00005R^LAB^151119:C5^35217|520.4200^IRON^Iron Studies Profile^^^50190-8||201911151403|201911151403|||||||201911151403||||||||||LAB|F||||
OBX|1|ST|520.4300^FE^Iron^^14798-3^14798-3|1|30^^Y|umol/L|9-30|N||A^S|F|||201911151411
OBX|2|ST|520.4500^TIBC^Total Iron Binding Capacity^^14800-7^14800-7|1|40^^Y|umol/L|45-70|L||A^S|F|||201911151411
OBX|3|ST|520.4600^TRFSAT^Transferrin Saturation^^6796-7^14801-5|1|0.75^^Y||0.15-0.55|H||A^S|C|||201911151412
NTE|1||Hyperferritinemia and elevated transferrin saturation index:
NTE|2||Patient meets criteria for HFE genetic testing as specified
NTE|3||in the current BC Guidelines.
NTE|4||   ****   CORRECTED RESULT  ****
NTE|5||   ---  15/11/19 1412 ---
NTE|6||  TRFSAT previously reported as: 0.75  H
NTE|7||
NTE|8||
NTE|9||Markedly elevated transferrin saturation.  Follow up and
NTE|10||management as per BCMA/MSP Iron Overload protocol.
OBR|3|35217^LAB|00027054^1511:C00005R^LAB^151119:C5^35217|520.4720^HFE HH^Hemochromatosis^^^XXX-1182||201911151403|201911151403|||||||201911151403||||||||||LAB|I||||